[Radiotherapy of carcinoma of the nasopharynx. Results and analysis of prognostic factors]
- PMID: 2244039
[Radiotherapy of carcinoma of the nasopharynx. Results and analysis of prognostic factors]
Abstract
Radiation therapy of the patients with nasopharyngeal carcinoma results in permanent loco-regional control in 55-100% of cases according to stage of disease. Five-year overall survival rates range 30-55% and 5-year disease-free survival 30-40%. Factors affecting survival are: sex, age, overall patient conditions, Epstein-Barr associated antibodies, histology, T and N stages, cranial nerve and neck nodes involvement, staging method, dose and fractionation of radiation therapy, and adjuvant treatment. Our results in 94 patients can be summarized as follows: 78.4% local control, 89.8% control of lymph nodes clinically palpable at diagnosis, 40% overall 5-year survival, and 38% 5-year disease-free survival. Significant prognostic factors in our series of patients were T and N stages and histology.
Similar articles
-
Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.Head Neck. 2004 May;26(5):389-95. doi: 10.1002/hed.10398. Head Neck. 2004. PMID: 15122654 Clinical Trial.
-
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.Cancer. 1999 Nov 1;86(9):1700-11. Cancer. 1999. PMID: 10547542
-
Prognostic features and treatment outcome in patients with nasopharyngeal carcinoma: an experience of 20 years.Anticancer Res. 2001 Mar-Apr;21(2B):1413-8. Anticancer Res. 2001. PMID: 11396224
-
[Radiotherapy of carcinoma of the nasopharynx].Ann Otolaryngol Chir Cervicofac. 1990;107(1):53-8. Ann Otolaryngol Chir Cervicofac. 1990. PMID: 2178540 Review. French.
-
Contribution of radiotherapy to function preservation and cancer outcome in primary treatment of nasopharyngeal carcinoma.World J Surg. 2003 Jul;27(7):838-43. doi: 10.1007/s00268-003-7109-2. World J Surg. 2003. PMID: 14509516 Review.
Cited by
-
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.Radiol Med. 2012 Jun;117(4):690-714. doi: 10.1007/s11547-011-0755-9. Epub 2011 Nov 17. Radiol Med. 2012. PMID: 22095424